Skip to content
DataLookout
Menu

NCT07944209

Remimazolam Induction Methods in Robotic Cholecystectomy

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Emergence time
Timeframe: From discontinuation of sevoflurane until MOAA/S score 5; assessed within 10 minutes.

Secondary (10)

Time to loss of responsiveness
Total remimazolam dose
Post-anesthesia care unit (PACU) stay duration
Postoperative pain score in PACU
Rescue analgesic doses in PACU
Show 5 moreShow less
Postoperative nausea and vomiting and rescue antiemetic use
Respiratory depression
Hemodynamic instability
Modified Aldrete score at PACU admission
Rescue flumazenil administration

Arms and interventions

Single-Bolus Remimazolam InductionActive comparator

Remimazolam 0.2 mg/kg administered as a single intravenous bolus for anesthetic induction.

Continuous-Infusion Remimazolam InductionExperimental

Remimazolam administered by continuous intravenous infusion at 12 mg/kg/hour for anesthetic induction.

Drugs: Remimazolam

Sites

1 site in 1 country

  • Korea University Ansan HospitalAnsan, Gyeonggi-do, South Korea